Skip to main content
. 2021 Mar 18;65(4):e01827-20. doi: 10.1128/AAC.01827-20

TABLE 2.

MIC distributions of studied antifungals versus isolates and rates of resistant/non-wild-type isolatesa

Organism(s) and drug No. of isolates at each MIC, in mg/liter
No. of isolates (%)
≤0.001 0.002 0.004 0.008 0.016 0.03 0.06 0.125 0.25 0.5 1 2 4 8 16 32 ≥64 Resistant Non-wild type
C. albicans (n = 410)
    Amphotericin B 0 0 0 0 12 98 217 78 5 0 0 0 0 (0) 0 (0)
    Fluconazole 28 239 125 12 2 0 0 1 0 0 3 4 (1.0) 6 (1.5)
    Voriconazole 4 46 280 61 11 2 2 0 0 1 0 0 0 3b 4 (1.0) 6 (1.5)
    Posaconazole 1 4 83 205 81 27 5 1 0 0 0 0 0 3b 4 (1.0) 4 (1.0)
    Isavuconazole 25 239 120 16 6 0 0 0 0 1 0 0 0 3b ND 4 (1.0)
    Micafungin 10 104 244 42 10 0 0 0 0 0 0 0 0 0 0 (0) 0 (0)
    Anidulafungin 13 178 190 19 9 1 0 0 0 0 0 0 0 0 0 (0) 0 (0)
C. parapsilosis complex (n = 237)
    Amphotericin B 0 0 0 0 4 20 105 101 7 0 0 0 0 (0) 0 (0)
    Fluconazole 0 3 116 93 22 3 0 0 0 0 0 0 (0) 0 (0)
    Voriconazole 0 0 16 125 78 15 3 0 0 0 0 0 0 0 0 (0) 0 (0)
    Posaconazole 0 0 0 10 76 106 45 0 0 0 0 0 0 0 0 (0) 0 (0)
    Isavuconazole 0 33 104 83 16 1 0 0 0 0 0 0 0 0 ND 0 (0)
    Micafungin 0 0 0 0 0 0 0 1 10 36 140 50 0 0 0 (0) 0 (0)
    Anidulafungin 0 0 0 0 0 0 1 0 3 14 53 153 13 0 0 (0) 0 (0)
C. glabrata (n = 110)
    Amphotericin B 0 0 0 0 3 14 65 27 1 0 0 0 0 (0) 0 (0)
    Fluconazole 0 0 0 0 0 5 37 49 9 2 8 10 (9.1) 10 (9.1)
    Voriconazole 0 0 0 0 0 2 15 35 47 4 2 4 1 0 ND 5 (4.5)
    Posaconazole 0 0 0 0 0 1 1 8 32 53 9 4 2 0 ND 6 (5.5)
    Isavuconazole 0 1 0 1 1 14 35 32 16 1 5 3 1 0 ND 10 (9.1)
    Micafungin 0 0 0 93 15 2 0 0 0 0 0 0 0 0 0 (0) 0 (0)
    Anidulafungin 0 0 0 0 41 64 4 1 0 0 0 0 0 0 1 (0.9) 1 (0.9)
C. tropicalis (n = 65)
    Amphotericin B 0 0 0 0 1 4 36 22 2 0 0 0 0 (0) 0 (0)
    Fluconazole 0 10 37 14 4 0 0 0 0 0 0 0 (0) 0 (0)
    Voriconazole 0 0 0 6 34 17 7 1 0 0 0 0 0 0 0 (0) 0 (0)
    Posaconazole 0 0 1 16 21 25 2 0 0 0 0 0 0 0 0 (0) 0 (0)
    Isavuconazole 0 3 28 31 2 1 0 0 0 0 0 0 0 0 ND 0 (0)
    Micafungin 0 0 0 3 44 15 1 1 0 0 0 1 0 0 ND 2 (3.1)
    Anidulafungin 0 0 0 15 38 8 3 0 0 0 0 1 0 0 1 (1.5) 1 (1.5)
C. krusei (n = 21)
    Amphotericin B 0 0 0 0 0 0 1 17 3 0 0 0 0 (0) 0 (0)
    Fluconazole 0 0 0 0 0 0 0 0 6 8 7 21 (100) 0 (0)
    Voriconazole 0 0 0 0 0 0 0 4 9 8 0 0 0 0 ND 0 (0)
    Posaconazole 0 0 0 0 1 2 4 8 6 0 0 0 0 0 ND 0 (0)
    Isavuconazole 0 0 0 0 0 0 2 12 6 1 0 0 0 0 ND 0 (0)
    Micafungin 0 0 0 0 0 0 15 6 0 0 0 0 0 0 ND 0 (0)
    Anidulafungin 0 0 0 0 0 14 7 0 0 0 0 0 0 0 0 (0) 0 (0)
Other Candida spp. (n = 28)
    Amphotericin B 0 0 0 2 6 10 6 4 0 0 0 0 ND ND
    Fluconazole 2 5 5 0 0 5 5 1 2 2 1 6 (21.4) ND
    Voriconazole 0 0 3 8 2 0 6 4 3 1 0 0 1 0 ND ND
    Posaconazole 0 0 2 2 8 2 5 3 6 0 0 0 0 0 ND ND
    Isavuconazole 0 5 5 3 0 2 3 5 1 3 0 1 0 0 ND ND
    Micafungin 0 1 0 1 6 4 4 5 2 3 0 1 1 0 ND ND
    Anidulafungin 0 0 1 7 2 3 3 0 2 2 6 2 0 0 ND ND
Non-Candida yeasts (n = 25)
    Amphotericin B 0 0 0 0 0 1 1 5 9 5 0 4b ND ND
    Fluconazole 0 0 0 2 5 1 5 1 1 2 8 ND ND
    Voriconazole 0 1 1 1 3 2 4 1 2 4 3 2 0 1b ND ND
    Posaconazole 0 0 0 2 3 5 5 3 4 3 0 0 0 0 ND ND
    Isavuconazole 0 1 1 1 5 2 6 1 2 3 1 2 0 0 ND ND
    Micafungin 0 0 0 0 0 0 0 1 0 1 0 1 1 21b ND ND
    Anidulafungin 0 0 0 0 0 0 0 0 0 2 0 1 2 20b ND ND
a

Underlined values indicate non-wild-type isolates according to ECOFFs, and values in bold indicate resistant isolates (EUCAST breakpoint table v 10.0), with the exception of C. krusei, which was considered intrinsically resistant to fluconazole (30, 31). —, nontested antifungal concentration. ND, not done, as either breakpoints or ECOFFs were not available.

b

Isolates with MICs of ≥8 mg/liter.